{
    "eid": "2-s2.0-84919961932",
    "title": "Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: A double blind, randomised, placebo controlled trial",
    "cover-date": "2014-12-01",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Behavioral Neuroscience",
            "@code": "2802"
        },
        {
            "$": "Psychiatry and Mental Health",
            "@code": "2738"
        }
    ],
    "keywords": [
        "Clinical research protocol",
        "Depression",
        "Inflammation",
        "Minocycline",
        "Oxidative stress"
    ],
    "authors": [
        "Olivia May Dean"
    ],
    "citedby-count": 47,
    "ref-count": 43,
    "ref-list": [
        "The World Health Report 2001. Mental Health: New Understanding, New Hope",
        "The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression",
        "Cytokines and major depression",
        "Antidepressant drugs and cytokines in mood disorders",
        "Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients",
        "Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness",
        "Lowered \u03c93 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients",
        "Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments",
        "Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression",
        "Oxidative damage and major depression: The potential antioxidant action of selective serotonin-re-uptake inhibitors",
        "Increased serum levels of 8-hydroxy-2\u2032-deoxyguanosine in clinical depression",
        "The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder",
        "Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression",
        "Clinical relevance of the neurotrophins and their receptors",
        "The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity",
        "Altered expression of neurotrophic factors in patients with major depression",
        "Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors",
        "Minocycline: Therapeutic potential in psychiatry",
        "Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells",
        "Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity",
        "Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage",
        "Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice",
        "A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons",
        "Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2",
        "A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: Translation initiator factor eIF4AI",
        "Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: A twelve-week follow-up study",
        "Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat",
        "Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia",
        "Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline",
        "Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells",
        "Antioxidant properties of minocycline: Neuroprotection in an oxidative stress assay and direct radical-scavenging activity",
        "Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine",
        "Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine",
        "Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats",
        "Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide",
        "Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline",
        "Does minocycline have antidepressant effect?",
        "Possible antipsychotic effects of minocycline in patients with schizophrenia",
        "Minocycline as adjunctive therapy for schizophrenia: An open-label study",
        "A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia",
        "Possible antidepressant effect of minocycline [11]",
        "Sample size calculations for clinical pharmacology studies",
        "Escitalopram dose-response revisited: An alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression"
    ],
    "affiliation": [
        {
            "affiliation-city": "Melbourne",
            "affilname": "University of Melbourne",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sydney",
            "affilname": "The University of Sydney School of Medicine",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "ORYGEN Youth Health",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sydney",
            "affilname": "CADE Clinic",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}